High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-09
DOI
10.1038/s41419-022-05044-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
- (2022) Chen Zhang et al. Molecular Cancer
- Transsulfuration, minor player or crucial for cysteine homeostasis in cancer
- (2022) Hai-Feng Zhang et al. TRENDS IN CELL BIOLOGY
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Antioxidant responses related to temozolomide resistance in glioblastoma
- (2021) José A. Campos-Sandoval et al. NEUROCHEMISTRY INTERNATIONAL
- Molecular analysis of the massive GSH transport mechanism mediated by the human Multidrug Resistant Protein 1/ABCC1
- (2020) Rachad Nasr et al. Scientific Reports
- The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy
- (2020) Yuechen Zhao et al. OncoTargets and Therapy
- xCT inhibitor sulfasalazine depletes paclitaxel‑resistant tumor cells through ferroptosis in uterine serous carcinoma
- (2020) Akiko Sugiyama et al. Oncology Letters
- A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
- (2020) Zhifang Hu et al. Frontiers in Oncology
- Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
- (2020) Han-jie Liu et al. Frontiers in Cell and Developmental Biology
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
- (2020) Pranavi Koppula et al. Protein & Cell
- NRF2‐dependent stress defense in tumor antioxidant control and immune evasion
- (2020) José Pedro Friedmann Angeli et al. Pigment Cell & Melanoma Research
- Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
- (2020) Clarissa Ribeiro Reily Rocha et al. Cells
- NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
- (2019) Matthew Dodson et al. Redox Biology
- A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity
- (2019) Jennifer Yinuo Cao et al. Cell Reports
- Glioblastoma vs temozolomide: can the red queen race be won?
- (2019) Anjali Arora et al. CANCER BIOLOGY & THERAPY
- Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma
- (2019) Petri Pölönen et al. ONCOGENE
- Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation
- (2019) Jiajun Zhu et al. Cell Metabolism
- The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells
- (2019) Matheus Molina Silva et al. Scientific Reports
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
- (2018) Irina Ingold et al. CELL
- Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
- (2018) Behrouz Hassannia et al. JOURNAL OF CLINICAL INVESTIGATION
- Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
- (2018) Daiha Shin et al. FREE RADICAL BIOLOGY AND MEDICINE
- VDAC2 enables BAX to mediate apoptosis and limit tumor development
- (2018) Hui San Chin et al. Nature Communications
- Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
- (2017) Z Fan et al. Oncogenesis
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Increased Expression of System x c − in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance
- (2016) Monika D. Polewski et al. MOLECULAR CANCER RESEARCH
- NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
- (2016) Clarissa Ribeiro Reily Rocha et al. Oncotarget
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells
- (2016) Haizhong Huo et al. PLoS One
- Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation
- (2015) M Hayano et al. CELL DEATH AND DIFFERENTIATION
- Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
- (2015) Min-Young Kwon et al. Oncotarget
- Emerging Therapies for Glioblastoma
- (2014) Alissa A. Thomas et al. JAMA Neurology
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Glutathione synthesis and its role in redox signaling
- (2012) Hongqiao Zhang et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A
- (2010) Sang Y. Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition
- (2010) Wen-bin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis
- (2008) José M. Matés et al. ARCHIVES OF TOXICOLOGY
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now